Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification-Reference-Cited by-同舟云学术

Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification

Published:2013-06-07 Issue:11 Volume:26 Page:1461-1467
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Lacle Miangela M,Kornegoor Robert,Moelans Cathy B,Maes-Verschuur Anoek H,van der Pol Carmen,Witkamp Arjen J,van der Wall Elsken,Rueschoff Josef,Buerger Horst,van Diest Paul J

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201394.pdf

Reference28 articles.

1. Kornegoor R, Moelans CB, Verschuur-Maes AH et al. Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res Treat 2012;135:49–58.

2. Hansen LL, Yilmaz M, Overgaard J et al. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 1998;58:2166–2169.

3. Wennmalm K, Calza S, Ploner A et al. Gene expression in 16q is associated with survival and differs between Sorlie breast cancer subtypes. Genes Chromosomes Cancer 2007;46:87–97.

4. Nordgard SH, Johansen FE, Alnaes GI et al. Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 2008;47:680–696.

5. Downing TE, Oktay MH, Fazzari MJ et al. Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer. Cancer Genet Cytogenet 2010;198:52–61.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive molecular characterization of a claudin-low luminal B breast tumor;Biology Direct;2024-08-16

2. Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance;Journal of Urology;2023-08

3. Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis;Genes;2023-07-28

4. Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review;The Lancet Oncology;2023-02

5. Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer;Cancers;2022-06-28